Navigation Links
Medicare Prescription Drug Benefit Shows Mixed Results
Date:4/22/2008

More getting drugs they need, but sickest still going without, study finds

TUESDAY, April 22 (HealthDay News) -- The Medicare Part D benefit has resulted in some improvements for seniors but no real revolution in prescription drug adherence.

A new report finds that Medicare beneficiaries are less likely to forego basic needs such as food to pay for medicine, but the sickest patients are still skipping meds due to burdensome costs.

"It's a mixed picture. We saw some things to be happy about and others to be concerned about," said study author Jeanne Madden, an instructor in the department of ambulatory care and prevention at Harvard Medical School in Boston. "Although this is the third year [of the program], the good data is just starting to come to the surface. It bears a lot of additional scrutiny."

Madden's study is in the April 23/30 issue of the Journal of the American Medical Association.

"This study reveals that the federal government has more work to do to assure that the Medicare Part D program meets the needs of the most vulnerable Medicare beneficiaries," Gail Shearer, director of health policy analysis at Consumers Union, said in a statement. "It is unacceptable that the sickest beneficiaries may not be filling prescriptions or taking the full doses or courses of their medicines because they simply can't afford to."

Medicare Part D, which provides drug benefits, took effect in January 2006. More than half of Medicare beneficiaries have enrolled in the program. Some 10 percent of beneficiaries still have no drug coverage, compared to up to 38 percent before the program took effect.

Surveys have shown that without adequate prescription drug benefits, seniors tend to skip doses, reduce doses or leave prescriptions unfilled. This, in turn, can result in serious health outcomes, including even heart attack and stroke.

Madden and her team looked at survey responses from 24,234 Medicare beneficiaries to determine how Medicare Part D had changed cost-related adherence to drug regimens.

In 2004 and 2005, before Part D, 15.2 percent and 14.1 percent of beneficiaries, respectively, skipped pills because of cost, versus 11.5 percent in 2006, after the program was implemented.

Similarly, in 2004 and 2005, 10.6 percent and 11.1 percent of beneficiaries, respectively, skimped on basic needs so as to be able to pay for medications, a percentage which declined to 7.6 percent in 2006.

The sickest individuals continued to skip pills at about the same rate both before and after Part D, although they were less likely to forego basic necessities. These beneficiaries are more likely to falling into the "donut hole," when drug costs are between $2,250 and $5,100, individuals have to pay the full cost of their drugs.

"This places a lot of burden on the sickest patients," Madden said. "[But] those sicker people aren't the only ones who are going to fall into the gap. The structure of that is pretty harsh. There's no coverage whatsoever for several thousand dollars."

A second study appearing in the same issue of the journal found that not only did Medicare beneficiaries enrolled in Part D still skip doses or switch to cheaper drugs, many do not understand the program.

The findings, conducted by researchers at Kaiser Permanente Medical Care Program in Oakland, Calif., were based on telephone interviews with about 1,000 Medicare beneficiaries in Northern California.

Only 40 percent of respondents knew that the new drug plan had a coverage gap (the "donut hole"). Thirty-six percent of respondents reported at least one cost-coping behavior. These behaviors were more common in households with lower incomes.

More information

Visit Consumer Reports for a free guide to prescription drugs.



SOURCES: Jeanne Madden, Ph.D., instructor, department of ambulatory care and prevention, Harvard Medical School, Boston; statement, Gail Shearer, Director of Health Policy Analysis, Consumers Union; April 23/30, 2008, Journal of the American Medical Association


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Medicare and Medicaid Data Released: Featuring Up-To-Date Enrollment Trends, State Initiatives, Regional Market Share and Prescription Drug Benefits
2. Medicare to consider public opinion about medical maggots
3. Avalere Health Data Finds Four-Tier System Growing Among Medicare Part D Plans
4. Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
5. RF Technologies Assists Healthcare Providers in Avoiding Preventable Injury Conditions to be Denied Reimbursement by Medicare
6. New Legislation Would Expedite Medicare Patient Access to Physical Therapy
7. New Medicare Equipment Bidding Program for Riverside, California Area is Rife with Errors, Says the American Association for Homecare
8. Medicare Bidding Program for Charlotte, N.C. is Plagued by Errors, Says American Association for Homecare
9. Medicare Bidding Program for Dallas, Texas is Rife with Errors, Says American Association for Homecare
10. ACP reports on how scheduled Medicare pay cuts will affect patients
11. Did Medicare Reimbursement Changes Affect Prostate Cancer Treatment?
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Medicare Prescription Drug Benefit Shows Mixed Results
(Date:12/5/2016)... ... December 05, 2016 , ... A ... Patch® significantly improves the reproducibility and accuracy of placing precordial electrodes with little ... , Over the last 60 years, studies have shown that single electrode misplacement ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... and many more tools allowing FCPX editors to create professional looking video in ... , Perfect Harmony contains a beautifully designed 3D environment for placing in ...
(Date:12/4/2016)... ... December 03, 2016 , ... Penrose Senior Care Auditors® ... area” Tuesday evening at the 26th Annual SMU Cox Dallas 100™ Awards Ceremony ... Caruth Institute for Entrepreneurship. Dallas 100™, co-founded by the Caruth Institute, honors the ...
(Date:12/4/2016)... Washington DC (PRWEB) , ... December 04, 2016 , ... ... Environmental, one of the most certified and experienced Indoor Air Quality Companies in VA, ... Assessment and Remediation Regulations. , The new mold law in the district ...
(Date:12/2/2016)... , ... December 02, 2016 , ... Lori G. ... Traurig, LLP’s Atlanta office, will speak at the American Conference Institute’s 21st Drug ... Traurig is also a Lead Sponsor of the conference. , Cohen, who chairs the ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... TAIPEI, Taiwan , Dec. 5, 2016 /PRNewswire/ ... ropeginterferon alfa-2b showed non-inferiority to hydroxyurea (HU) in Complete Hematologic ... safety and tolerability profile of ropeginterferon alfa-2b versus HU ... the ongoing long-term follow-up trial CONTINUATION-PV to obtain European marketing ... to present this data to the FDA as it seeks ...
(Date:12/4/2016)...   Pairnomix, LLC, a genetic research company and ... the White House, today announced that findings from its first ... candidate therapies for a patient with epileptic encephalopathy caused by ... at the 70 th Annual Meeting of the ... , December 2-6, 2016.  Pairnomix, unique process involves ...
(Date:12/4/2016)... Dec. 3, 2016  Findings from a Novartis ... CTL019, an investigational chimeric antigen receptor T cell ... young adult patients with B-cell acute lymphoblastic leukemia ... session at the 58th American Society of Hematology ... p.m.). The global Phase II study found that ...
Breaking Medicine Technology: